MetaCap

Protalix BioTherapeutics (DE) Insider Trades

NYSE: PLXHealth CareBiotechnology: Biological Products (No Diagnostic Substances)USD

2.90-0.16 (-5.23%)

At close: Nov 20, 4:00 PM ET · Delayed 15 min

Last 12 months

Purchases
1 · $101.36K
Sales
0 · $0
Shares bought / sold
56.00K / 0
Net activity
Net buying $101,360

Protalix BioTherapeutics (DE) insider activity

Over the last 12 months, Protalix BioTherapeutics (DE) insiders reported 1 transaction on SEC Form 4: 1 open-market purchase and 0 sales. Insiders bought $101,360 and sold $0 worth of stock, for net insider buying of $101,360. The most recent filing shows Bashan Dror (PRESIDENT AND CEO) buying 56,000 shares at $1.81 on Dec 19, 2025.

Insider sales are common for compensation, tax and diversification reasons, while open-market purchases are rarer; tracking both helps put PLX's ownership changes in context.

Summary generated from market data by MetaCap's automated system. Methodology

PLX insider transactions

Protalix BioTherapeutics (DE) insider transactions
DateInsiderTypeSharesValueFiling
Dec 19, 2025Bashan DrorPRESIDENT AND CEOBuy56,000$101.36KForm 4
Nov 18, 2025Bar-Shalev AmosDirectorSale168$314.16Form 4
Sep 3, 2025Naos YaronSr. VP, OperationsAward25,000—Form 4
Sep 3, 2025Bar-Shalev AmosDirectorAward7,500—Form 4
Sep 3, 2025Forster EliotDirectorAward7,500—Form 4
Sep 3, 2025Bashan DrorPRESIDENT AND CEOAward195,000—Form 4
Sep 3, 2025Ben Zvi ShmuelDirectorAward7,500—Form 4
Sep 3, 2025Schwartz AharonDirectorAward7,500—Form 4
Sep 3, 2025Melincoff Gwen ADirectorAward7,500—Form 4
Sep 3, 2025Elze ChristianDirectorAward7,500—Form 4
Sep 3, 2025Boudes Pol FDirectorAward7,500—Form 4
Jun 10, 2025Schwartz AharonDirectorBuy129,000$205.88KForm 4
Sep 23, 2024Rubin EyalSr. VP and CFOAward99,010—Form 4
Sep 23, 2024Rubin EyalSr. VP and CFOAward90,909—Form 4
Apr 1, 2024Bashan DrorPRESIDENT AND CEOAward263,960—Form 4
Oct 19, 2023Bashan DrorPRESIDENT AND CEOBuy16,129$22.74KForm 4
Oct 19, 2023Bashan DrorPRESIDENT AND CEOBuy48,387$67.74KForm 4
Aug 15, 2023Bashan DrorPresident and CEOAward800,000—Form 4
Aug 15, 2023Naos YaronSr. VP, OperationsAward187,344—Form 4
Aug 15, 2023Hayon YaelVP, Research & DevelopmentAward35,115—Form 4
Aug 15, 2023Rubin EyalSr. VP and CFOAward201,903—Form 4
Jan 3, 2023Schwartz AharonDirectorBuy110,000$155.81KForm 4

Transaction codes follow SEC Form 4: P = open-market purchase, S = open-market sale, A = grant or award, M = option exercise, F = shares withheld for taxes. About Form 4

Related